Results 1 to 10 of about 10,940 (211)

Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies. [PDF]

open access: yesWorld J Gastroenterol, 2021
Zollinger-Ellison syndrome (ZES) associated with pancreatic or duodenal gastrinoma is characterized by gastric acid hypersecretion, which typically leads to gastroesophageal reflux disease, recurrent peptic ulcers, and chronic diarrhea.
Rossi RE   +6 more
europepmc   +2 more sources

Radiological Features of Zollinger–Ellison Syndrome: A Report of Two Cases [PDF]

open access: yesIndian Journal of Radiology and Imaging, 2022
Hypersecretion of gastrin from duodenal or pancreatic gastrinomas results in a rare clinical entity called Zollinger–Ellison syndrome (ZES). It mostly presents with abdominal pain and diarrhea.
Thara Pratap   +5 more
doaj   +2 more sources

Postsurgical Presentation of Zollinger-Ellison Syndrome After Resection of Endometrioid Neuroendocrine Tumor. [PDF]

open access: yesACG Case Rep J, 2021
Zollinger-Ellison syndrome is a functional neuroendocrine tumor with inappropriate gastrin secretion and hyperchlorhydria causing severe peptic ulcer disease and chronic diarrhea.
Almuhaidb A, Davidson NO.
europepmc   +3 more sources

Zollinger-Ellison Syndrome - review [PDF]

open access: yesJournal of Education, Health and Sport, 2022
Introduction and purpose Zollinger-Ellison syndrome (ZES) is a constellation of symptoms that includes gastric ulcer, gastroesophageal reflux disease (GERD), and chronic diarrhea.
Jakub Metelski   +4 more
doaj   +3 more sources

Ga-68 DOTATATE PET/CT in a patient with Zollinger-Ellison syndrome [PDF]

open access: yesRadiology Case Reports, 2023
This case report follows a 70-year-old male patient with Zollinger-Ellison syndrome undergoing computed tomography (CT) for weight loss and surveillance of bilateral adrenal nodules. Incidentally, diffuse gastric and duodenal wall thickening was noted on
Migara Jayasekera, BS   +2 more
doaj   +2 more sources

Zollinger-Ellison syndrome. [PDF]

open access: yesCMAJ, 2019
A 25-year-old man previously diagnosed with irritable bowel syndrome (2–3 loose stools per day) presented for esophagogastroduodenoscopy because of increasing epigastric discomfort. Numerous peptic complications were found during the procedure ([Figure 1A–1D][1]).
Zimmer V, Glanemann M, Lammert F.
europepmc   +5 more sources

Primary hyperparathyroidism and Zollinger Ellison syndrome during pregnancy: a case report [PDF]

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2021
Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited endocrine disorder with a high rate of penetrance. The incidence of MEN1 is 1/30,000 in the general population; however, it is quite rare for a patient to present for medical attention with ...
Dalal Ali   +5 more
doaj   +2 more sources

Current Medical Controversies in Zollinger–Ellison Syndrome [PDF]

open access: yesBiomedicines
Purpose: Zollinger–Ellison syndrome (ZES) is the most frequent, functional, malignant pancreatic neuroendocrine tumor syndrome (pNET), which is due to ectopic secretion of gastrin by a pNET/NET (i.e., gastrinomas) resulting in severe, refractory acid ...
Robert T. Jensen   +2 more
doaj   +2 more sources

Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies. [PDF]

open access: yesWorld J Gastroenterol, 2019
Zollinger-Ellison syndrome (ZES) is characterized by gastric acid hypersecretion causing severe recurrent acid-related peptic disease. Excessive secretion of gastrin can now be effectively controlled with powerful proton pump inhibitors, but surgical ...
Shao QQ   +4 more
europepmc   +2 more sources

Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome. [PDF]

open access: yesInt J Mol Sci, 2019
The use of proton pump inhibitors (PPIs) over the last 30 years has rapidly increased both in the United States and worldwide. PPIs are not only very widely used both for approved indications (peptic ulcer disease, gastroesophageal reflux disease (GERD),
Lee L   +3 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy